
Neopharmed Gentili S.p.A.
- Home
- Companies
- Neopharmed Gentili S.p.A.
- Applications
- Medical solutions for mild cognitive ...

Medical solutions for mild cognitive impairment - Medical / Health Care
Mild Cognitive Impairment (MCI) is a clinical condition that affects one or more cognitive domains (memory, language, concentration). Nearly 900 thousand Italians are affected by it and it is prevalent from the age of 60. It is the first indicator of a disease that can become increasingly disabling and compound over time, increasing the risk of dementia. It is the transitional phase between normal aging and dementia, during which it is possible to intervene and delay the onset of the latter.
Stay in the loop!
Select your areas of interest to receive industry updates.